Brain Tumor News!
Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!
10/25/01
Introgen's INGN 241 Gene Drug Demonstrates Tumor Growth Control
(PR Newswire)
...First, how MDA-7 protein is regulated as
tumors develop from benign moles to the full-blown skin cancer known as melanoma and secondly,......This study demonstrates that mda-7 is a key
tumor suppressor gene whose function is lost as melanoma
tumors grow more aggressively....... trials for INGN 201 in additional cancer indications including prostate, ovarian, bladder,
brain, and breast cancer....
10/24/01
Since September 11, TWA Flight 800 controversy rages again
(CourtTV)
A
brain tumor ended the life of William Donaldson on August 22, but the 56-year-old retired Navy commander's mission to prove that a missile brought down TWA Flight 800 five years ago lives on through his Web site.
10/23/01
Officials Apologize to Harrison
(AP)
... time telling his fans not to worry and refused to comment on reports that he was battling a
brain tumor. ...
10/23/01
Gene Associated With Cancer and Other Diseases Awarded Patent and Licensed By Introgen
(PR Newswire)
... collaborated since 1998 in the identification and pre- clinical development of a number of
tumor suppressor genes.......Adenoviral-PTEN significantly slows the growth of human
tumors, grown in animal models....... trials for INGN 201 in additional cancer indications including prostate, ovarian, bladder,
brain, and breast cancer....
10/22/01
CTF Systems Inc. Announces $4.1 Million Sale to University of Kansas
(CCN Newswire)
VANCOUVER, BRITISH COLUMBIA--CTF Systems Inc., a wholly owned subsidiary of VSM MedTech Ltd., today announced that it has received an order from the University of Kansas Medical Center in Kansas City, Kansas to build and install two magnetoencephalography imaging systems; a 151-channel whole cortex system and an 83-channel fetal MEG system . The value of the contract is CDN$4.1 million. These two MEG systems will play an integral role in the research conducted at the state-of-the-art Hoglund
Brain...
10/22/01
Immune System Therapy Helps Skin Cancer Patients
(Reuters)
... to boost the immune system of melanoma patients after they have had surgery to remove skin
tumors.......The treatment is based on cells called
tumor infiltrating lymphocytes (TILS) that produce a reaction against the cancer....... spread rapidly throughout the body, forming secondary
tumors in the liver, lungs, bones and
brain....
10/22/01
Introgen to Present at Techvest Healthcare Conference
(PR Newswire)
... trials for INGN 201 in additional cancer indications including prostate, ovarian, bladder,
brain, and breast cancer.......Introgen's second product candidate, INGN 241 (Adenoviral-mda7) for the treatment of solid
tumors, is in Phase I clinical development....
10/19/01
Protein Gives Clue to MS, Other Diseases
(Reuters)
...If scientists can harness the repair skills of the molecule, known as
tumor necrosis factor-alpha (TNF-a), they may be able to develop new treatments for MS and other......--the thin, protective coating that insulates nerve fibers in the
brain and spine....
10/18/01
Thalidomide: Single-handed Cancer Fighter?
(HealthSCOUT)
...After surgery to remove the first
tumor, two other sores appeared nearby.......When an immune-stimulating vaccine didn't shrink the new
tumors, the man began taking 200 milligrams a day of thalidomide....... thalidomide and another cancer drug, temozolomide, could treat melanoma that had spread to the
brain....
10/18/01
Allos Therapeutics Reports Third Quarter 2001 Financial Results
(PR Newswire)
...''Patient accrual for our Phase III randomized study of RSR13 combined with standard whole
brain radiation therapy versus standard whole
brain radiation therapy alone for the treatment of......The Company is conducting a pivotal Phase III trial for the treatment of metastatic
brain tumors with its lead clinical candidate, RSR13.......By increasing
tumor oxygenation, RSR13 has the potential to enhance the efficacy of standard radiation therapy...
